Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ginkgo Bioworks Hldgs Inc
(NY:
DNA
)
0.2340
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ginkgo Bioworks Hldgs Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Billionaire Andreas Halvorsen Just Bought DNA Stock. Here’s Why.
July 07, 2022
DNA stock is surging higher today following large purchases from Viking Global's Andreas Halvorsen and Ark Invest's Cathie Wood.
Via
InvestorPlace
Beware These 7 Penny Stock Bubbles Getting Ready to Burst
July 06, 2022
The following penny stocks have built up a large bubble that is yet to burst. They are likely to burst soon due to the market decline.
Via
InvestorPlace
Is TSLA Stock Still a Buy? 5 Analysts Weigh In.
July 05, 2022
Tesla (TSLA) stock is a hot topic on Tuesday as analysts react to the company's EV deliveries for the second quarter of 2022.
Via
InvestorPlace
Cathie Wood Is Making a Big Bet on Gingko Bioworks (DNA) Stock
July 05, 2022
Cathie Wood's Ark Invest has purchased more than 3.5 million shares of DNA stock since June 29, its first purchases in over a month.
Via
InvestorPlace
Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group
June 23, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity...
Via
Benzinga
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
May 20, 2022
Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares.
Via
InvestorPlace
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
May 19, 2022
DNA stock is a falling knife in 2022, and the latest earnings do not justify being optimistic about reaching profitability soon.
Via
InvestorPlace
Why Ginkgo Bioworks Stock Is Falling After Hours
May 16, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company
Via
Benzinga
Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone
June 21, 2022
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership
Via
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?
Via
InvestorPlace
ADSK Stock Sinks 8% Following Analyst Downgrade
May 23, 2022
Autodesk (ADSK) stock is slipping on Monday after getting hit with a downgrade and price target drop from Deutsche Bank analyst Bhavin Shah.
Via
InvestorPlace
Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood
May 21, 2022
Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
April 13, 2022
Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result.
Via
InvestorPlace
74 Biggest Movers From Yesterday
June 03, 2022
Gainers
Via
Benzinga
Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock
May 19, 2022
Ark Investment Management, led by Tesla Inc.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
May 18, 2022
Via
Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
May 18, 2022
While Ginkgo Bioworks Holdings Inc’s (NYSE: DNA) overall first-quarter results were better than expected, revenues and active programs in its core Foundry segment fell short of estimates, according to...
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
May 17, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday.
Via
Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
May 13, 2022
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 9.65% since its last report. The company recently reported that it has 81.30 million shares sold short,...
Via
Benzinga
7 Growth Stocks to Buy on the Dip
May 10, 2022
Although the wave of red ink in the major indices is intimidating, it also presents an intriguing opportunity for growth stocks to buy.
Via
InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
April 27, 2022
DNA stock is in the spotlight after Ark Invest reported purchasing more than 1.5 million shares this week. So, who else is betting big on Ginkgo?
Via
InvestorPlace
7 Biggest Loser Stocks That Could Become Surprising Buys
April 27, 2022
A huge pouring of red ink can sometimes lead to extraordinary gains, though you’ve got to be aware of the risks.
Via
InvestorPlace
28 Biggest Movers From Yesterday
April 14, 2022
Gainers HighPeak Energy, Inc. (NASDAQ: HPK) shares gained 31.76% to close at $28.83 on Wednesday, after CNBC’s Jim Cramer said the mid-cap company is an aggressive play on...
Via
Benzinga
NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc.
April 13, 2022
San Diego, CA -- (SBWIRE) -- 04/13/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Ginkgo Bioworks Holdings, Inc.
Via
SBWire
Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm
April 11, 2022
Elanco Animal Health Incorporated (NYSE: ELAN) and Ginkgo Bioworks Holdings Inc (NYSE: DNA) have launched BiomEdit, a microbiome innovation company....
Via
Benzinga
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
April 07, 2022
Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio.
Via
InvestorPlace
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
April 05, 2022
From
Twist Bioscience Corporation
Via
Business Wire
53 Biggest Movers From Yesterday
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.